標題: Three months of rifapentine and isoniazid for latent tuberculosis infection in hemodialysis patients: High rates of adverse events
作者: Lin, Shang-Yi
Chiu, Yi-Wen
Lu, Po-Liang
Hwang, Shang-Jyh
Chen, Tun-Chieh
Hsieh, Min-Han
Chen, Yen-Hsu
生醫工程研究所
Institute of Biomedical Engineering
關鍵字: Rifapentine;3HP;Latent tuberculosis;LTBI;Hemodialysis
公開日期: 1-Feb-2019
摘要: The consequences of once-weekly rifapentine plus isoniazid for 3 months (3HP) against latent tuberculosis infections in hemodialysis patients have not been studied before. This is the first study to evaluate the safety and tolerability of 3HP in this population and revealed a completion rate of 65.4%. The therapy was not associated with hepatotoxicity, but with high rates of adverse events (69.2%). Copyright (C) 2018, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
URI: http://dx.doi.org/10.1016/j.jmii.2018.05.003
http://hdl.handle.net/11536/148871
ISSN: 1684-1182
DOI: 10.1016/j.jmii.2018.05.003
期刊: JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
Volume: 52
起始頁: 158
結束頁: 162
Appears in Collections:Articles


Files in This Item:

  1. e0a7697baffc0d40777ed0afe38fbe27.pdf